Savara Inc
NASDAQ:SVRA

Watchlist Manager

Savara Inc

NASDAQ:SVRA

Watchlist

Dividends

Price: 2.86 USD -11.18% Market Closed

Market Cap: 493.7m USD

Have any thoughts about
Savara Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 2.86 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

SVRA Alert

Savara Inc

2.86

-0.36 (-11.18%)

52 Week Range	2.32 5.07
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Savara Inc

What unique competitive advantages
does Savara Inc hold over its rivals?

What risks and challenges
does Savara Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Savara Inc.

What unique competitive advantages
does Savara Inc hold over its rivals?

What risks and challenges
does Savara Inc face in the near future?

Has there been any significant insider trading activity
in Savara Inc recently?

Summarize the latest earnings call
of Savara Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Savara Inc.

Provide P/S
for Savara Inc.

Provide P/E
for Savara Inc.

Provide P/OCF
for Savara Inc.

Provide P/FCFE
for Savara Inc.

Provide P/B
for Savara Inc.

Provide EV/S
for Savara Inc.

Provide EV/GP
for Savara Inc.

Provide EV/EBITDA
for Savara Inc.

Provide EV/EBIT
for Savara Inc.

Provide EV/OCF
for Savara Inc.

Provide EV/FCFF
for Savara Inc.

Provide EV/IC
for Savara Inc.

Show me price targets
for Savara Inc made by professional analysts.

What are the Revenue projections
for Savara Inc?

How accurate were the past Revenue estimates
for Savara Inc?

What are the Net Income projections
for Savara Inc?

How accurate were the past Net Income estimates
for Savara Inc?

What are the EPS projections
for Savara Inc?

How accurate were the past EPS estimates
for Savara Inc?

What are the EBIT projections
for Savara Inc?

How accurate were the past EBIT estimates
for Savara Inc?

Compare the revenue forecasts
for Savara Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Savara Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Savara Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Savara Inc compared to its peers.

Compare the P/E ratios
of Savara Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Savara Inc with its peers.

Analyze the financial leverage
of Savara Inc compared to its main competitors.

Show all profitability ratios
for Savara Inc.

Provide ROE
for Savara Inc.

Provide ROA
for Savara Inc.

Provide ROIC
for Savara Inc.

Provide ROCE
for Savara Inc.

Provide Gross Margin
for Savara Inc.

Provide Operating Margin
for Savara Inc.

Provide Net Margin
for Savara Inc.

Provide FCF Margin
for Savara Inc.

Show all solvency ratios
for Savara Inc.

Provide D/E Ratio
for Savara Inc.

Provide D/A Ratio
for Savara Inc.

Provide Interest Coverage Ratio
for Savara Inc.

Provide Altman Z-Score Ratio
for Savara Inc.

Provide Quick Ratio
for Savara Inc.

Provide Current Ratio
for Savara Inc.

Provide Cash Ratio
for Savara Inc.

What is the historical Revenue growth
over the last 5 years for Savara Inc?

What is the historical Net Income growth
over the last 5 years for Savara Inc?

What is the current Free Cash Flow
of Savara Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Savara Inc.

Savara Inc
Investor Relations

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The company is headquartered in Austin, Texas and currently employs 22 full-time employees. The company went IPO on 2001-06-25. The firm is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of aPAP. Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the build-up of surfactant in the alveoli or air sacs of the lungs.

SVRA

S&P 500

1Y 3Y 5Y 10Y 15Y 20Y

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Savara Inc

Business Overview

Earnings Calls

Show Transcript

Management

Mr. Matthew Pauls J.D., M.B.A.

Chairman & CEO

No Bio Available

Mr. David L. Lowrance CPA

CFO, Chief Administrative Officer & Secretary

No Bio Available

Mr. Robert Lutz M.B.A.

Chief Operating Officer

No Bio Available

Ms. Kate McCabe J.D.

Senior VP & General Counsel

No Bio Available

Ms. Anne Erickson

Chief Business Officer

No Bio Available

Brian Maurer

Head of Clinical Operations

No Bio Available

Mr. Charles LaPree

Senior Vice President of Global Regulatory Affairs & Quality Assurance

No Bio Available

Dr. Peter Clarke Ph.D.

Executive Vice President of Global Technical Operations

No Bio Available

Dr. Raymond Dennis Pratt FACP, M.D.

Chief Medical Officer

No Bio Available

Mr. Scott L. Wilhoit

Executive Vice President of Global Commercial

No Bio Available

Contacts

Address

TEXAS

Austin

6836 Bee Cave Road, Building 3, Suite 201

Contacts

+15126141848.0

savarapharma.com

sparklesyt

	Franklin Covey Co NYSE:FC	21.1 USD -1.08%
	Mohawk Industries Inc NYSE:MHK	110.94 USD 4.36%
	Ardmore Shipping Corp NYSE:ASC	9.83 USD -0.91%
	ASGN Inc NYSE:ASGN	57.37 USD 3.02%
	Skyworks Solutions Inc NASDAQ:SWKS	73.04 USD 7.08%
	Weatherford International PLC NASDAQ:WFRD	49.2 USD 6.79%

	Johnson & Johnson NYSE:JNJ	154.14 USD -0.05%
	Bank of America Corp NYSE:BAC	43.36 USD 3.76%
	Mastercard Inc NYSE:MA	578.27 USD 1.69%
	Salesforce Inc NYSE:CRM	288.82 USD 4.87%
	Abbvie Inc NYSE:ABBV	190.5 USD 3.2%
	Home Depot Inc NYSE:HD	376.59 USD 3.83%

	Arista Networks Inc NYSE:ANET	92.32 USD 6.7%
	Visa Inc NYSE:V	355.85 USD 0.94%
	Texas Pacific Land Corp NYSE:TPL	1 341.12 USD 3.05%
	KLA Corp NASDAQ:KLAC	760.47 USD 8.45%
	Manhattan Associates Inc NASDAQ:MANH	195.47 USD 6.02%
	Monolithic Power Systems Inc NASDAQ:MPWR	709.23 USD 11.2%

	ServiceNow Inc NYSE:NOW	1 015.6 USD 3.63%
	Spotify Technology SA NYSE:SPOT	620.32 USD -4.31%
	EOG Resources Inc NYSE:EOG	114.06 USD 2.65%
	Monster Beverage Corp NASDAQ:MNST	61.36 USD 0.59%
	Copart Inc NASDAQ:CPRT	62.16 USD 1.04%
	Applied Materials Inc NASDAQ:AMAT	167.99 USD 7.96%

Savara Inc
NASDAQ:SVRA

Savara Inc
Investor Relations

Earnings Calls

Management

Contacts

See Also

Company

Help

Tools

Stocks

Savara Inc NASDAQ:SVRA

Savara Inc Investor Relations

Earnings Calls

Management

Contacts

See Also

Company

Help

Tools

Stocks

Savara Inc
NASDAQ:SVRA

Savara Inc
Investor Relations